InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Karande Mahesh, Chief Executive Officer. Director active across 1 company, notably Omega Therapeutics, Inc.. In total, 1 filings have been published. Activity tracked since 1 February 2022. The latest transaction was filed on 1 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Karande Mahesh is President and Chief Executive Officer of Omega Therapeutics, Inc. In this role, he is responsible for the strategic direction of the company, which focuses on developing innovative therapies. Under his leadership, Omega Therapeutics is committed to improving treatments for patients. Karande has a strong background in the biopharmaceutical sector and is recognized for his ability to lead teams toward innovation.